Ad is loading...
IKT
Price
$2.05
Change
-$0.31 (-13.14%)
Updated
Nov 15 closing price
NOXOF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
May 15 closing price
Ad is loading...

IKT vs NOXOF

Header iconIKT vs NOXOF Comparison
Open Charts IKT vs NOXOFBanner chart's image
Inhibikase Therapeutics
Price$2.05
Change-$0.31 (-13.14%)
Volume$400.09K
CapitalizationN/A
Noxopharm
Price$0.04
Change-$0.00 (-0.00%)
Volume$2.3K
CapitalizationN/A
IKT vs NOXOF Comparison Chart
Loading...
IKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
IKT vs. NOXOF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKT is a StrongSell and NOXOF is a Buy.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (IKT: $2.05 vs. NOXOF: $0.05)
Brand notoriety: IKT and NOXOF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKT: 63% vs. NOXOF: 100%
Market capitalization -- IKT: $134.84M vs. NOXOF: $23.72M
IKT [@Biotechnology] is valued at $134.84M. NOXOF’s [@Biotechnology] market capitalization is $23.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKT’s FA Score shows that 0 FA rating(s) are green whileNOXOF’s FA Score has 0 green FA rating(s).

  • IKT’s FA Score: 0 green, 5 red.
  • NOXOF’s FA Score: 0 green, 5 red.
According to our system of comparison, NOXOF is a better buy in the long-term than IKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKT’s TA Score shows that 6 TA indicator(s) are bullish.

  • IKT’s TA Score: 6 bullish, 4 bearish.

Price Growth

IKT (@Biotechnology) experienced а -28.82% price change this week, while NOXOF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

IKT is expected to report earnings on Nov 14, 2023.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IKT($135M) has a higher market cap than NOXOF($23.7M). IKT YTD gains are higher at: 61.417 vs. NOXOF (50.000).
IKTNOXOFIKT / NOXOF
Capitalization135M23.7M570%
EBITDA-18.98MN/A-
Gain YTD61.41750.000123%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash7.94MN/A-
Total Debt178KN/A-
TECHNICAL ANALYSIS
Technical Analysis
IKT
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Ad is loading...
IKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSYIX10.75N/A
N/A
AMG TimesSquare Global Small Cap I
MADCX24.32-0.17
-0.69%
BlackRock Emerging Mkts Instl
ABWCX15.10-0.11
-0.72%
AB All Market Total Return C
LOVLX38.09-0.32
-0.83%
Lord Abbett Mid Cap Stock F3
CAABX26.55-0.34
-1.26%
ClearBridge Sustainability Leaders C

NOXOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NOXOF has been loosely correlated with NWPHF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NOXOF jumps, then NWPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NOXOF
1D Price
Change %
NOXOF100%
N/A
NWPHF - NOXOF
54%
Loosely correlated
N/A
NTRB - NOXOF
29%
Poorly correlated
-3.27%
BCRX - NOXOF
26%
Poorly correlated
-5.64%
IKT - NOXOF
23%
Poorly correlated
-13.14%
EYEN - NOXOF
21%
Poorly correlated
-70.04%
More